GC녹십자웰빙 has entered the Japanese market by showcasing its aesthetic products at a Japanese aesthetic medicine academic conference.

GC녹십자웰빙 announced on the 7th that it participated in the “ASLS TOKYO 2026,” the Japan academic conference of the Korean Academy of Aesthetic Surgery & Laser, held in Tokyo, Japan, on the 28th of last month, and operated a joint promotional booth with its local partner Nifuji.

More than 30 global medical aesthetic companies and around 500 cosmetic and plastic surgery practitioners and industry officials from across Asia attended the conference.

At the event, GC녹십자웰빙 introduced its aesthetic products, including the ECM (extracellular matrix) skin booster “Rebornne,” as well as “Gisele PDRN 2.5” and “Gisele PDRN 2.0.”

According to the company, about 100 Japanese medical professionals visited the booth during the conference to receive product explanations, and they also expressed interest in a local seminar scheduled to be held this month.

The event also featured an academic lecture by Dr. Yoo Kyung-hoon of Lumi Clinic on “ECM Therapy Based on Acellular Allogeneic Dermis,” in which he presented treatment strategies and clinical application cases using Rebornne.

Recently, domestic medical aesthetic companies have been stepping up their overseas market strategies by expanding participation in academic conferences and seminars for medical professionals, mainly in Japan and Southeast Asia. Industry observers view academic exchanges and partnership building with local medical professionals as an important strategy that enhances product credibility and establishes a foundation for market entry.

A GC녹십자웰빙 official said, “We are strengthening partnerships in the Japanese market and expanding academic marketing targeting local medical professionals,” adding, “We plan to continue our global market expansion through overseas market-tailored academic activities and a diverse portfolio of aesthetic products.”

Popular News